Search

Displaying results 4551 - 4560 of 4589 in total
  1. Drug

    Coumarin

    go.drugbank.com/drugs/DB04665
    Investigational

    Categories: Vitamin K Antagonists
  2. Drug

    Menadione bisulfite

    go.drugbank.com/drugs/DB15944
    Investigational

    Mixtures: HEMOSIN K, HEMOSIN-KCategories: Vitamin K
  3. Drug

    Azetukalner

    go.drugbank.com/drugs/DB21551
    Investigational

    The usage of the INN stem '-kalner' in the name indicates that Azetukalner is a opener of calcium-activated (maxi-K) K+-channel.

  4. Drug

    N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide

    go.drugbank.com/drugs/DB03456
    Experimental

    It is known to target cathepsin K.

  5. Drug

    Tipifarnib

    go.drugbank.com/drugs/DB04960
    Investigational

    Tipifarnib (R-115777) is a substance that is being studied in the treatment of acute myeloid leukemia (AML) and other types of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors. It is also called Zarnestra. ...

  6. Drug

    ACTX-401

    go.drugbank.com/drugs/DB18504
    Experimental

    ACTX-401 is a single-stranded, non-replicating recombinant adeno-associated viral vector serotype 9 containing the human immunoglobulin u-binding protein 2 cDNA.

  7. Drug

    U-0126

    go.drugbank.com/drugs/DB17060
    Experimental

    U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and MEK-2.[A253162]

    Salts: U-0126-EtOH
  8. Drug

    NC-6300

    go.drugbank.com/drugs/DB17341
    Experimental

    NC-6300, also known as K-912, is a novel [epirubicin] drug-conjugated polymeric micelle.

  9. Drug

    Pifusertib

    go.drugbank.com/drugs/DB15054
    Investigational

    TAS-117 is under investigation in clinical trial NCT03017521 (K-BASKET, TAS-117, PI3K/AKT Gene Aberration).

  10. Drug

    Menaquinone

    go.drugbank.com/drugs/DB15381
    Investigational

    Menaquinone is under investigation in clinical trial NCT01533441 (Vitamin K2 Intervention in Patients With Vitamin K Antagonists).

    Categories: Vitamin K, Vitamin K 2